Sedation management in the ICU
Sedation in ICU
DOI:
https://doi.org/10.25751/rspa.24797Keywords:
deep sedation, conscious sedation, critically ill, delirium, pain, circadian dysregulationAbstract
Introduction
Sedation in intensive care seems to have implications in the critical patient prognosis. Subsequently, it is important to review the most recent literature and bring general recommendations to each clinical scenario and to the Portuguese approach.
Methods
A non-systematic revision was performed and finished in December 2020. PubMed database was used with the following keywords: sedation, critically ill, intensive care, delirium, circadian dysregulation.
Results and discussion
Any sedation strategy should include several drugs and should start by patient analgesia. Afterwards, sedation should aim the lightest level for the shortest time duration.
Drug choice is dictated by the clinical scenario. An analysis of drug choice according to some frequent clinical scenarios is made.
Conclusion
Sedation in ICU should be multimodal and frequently re-adjusted to each patient and to each clinical scenario. The best practice standards of looking for the minimal sedation to keep the patient comfortable and safe should keep primacy.
Downloads
References
DeBiasi EM, Akgün KM, Pisani M. Awake or Sedated: Trends in the Evaluation and Management of Agitation in the Intensive Care Unit. Semin Respir Crit Care Med. 2015;36(6):899-913.
Devlin JW, Skrobik Y, Gélinas C, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Vol 46.; 2018.
Schenone AL, Chen K, Andress K, Militello M, Cho L. Editor’s Choice- Sedation in the coronary intensive care unit: An adapted algorithm for critically ill cardiovascular patient. Eur Hear journal Acute Cardiovasc care. 2019;8(2):167-175.
Opdenakker O, Vanstraelen A, De Sloovere V, Meyfroidt G. Sedatives in neurocritical care: an update on pharmacological agents and modes of sedation. Curr Opin Crit Care. 2019;25(2):97-104.
Pearson SD, Patel BK. Evolving targets for sedation during mechanical ventilation. Curr Opin Crit Care. 2020;26(1):47-52.
Desbiens NA, Wu AW, Broste SK, et al. Pain and satisfaction with pain control in seriously ill hospitalized adults: Findings from the SUPPORT research investigations. Crit Care Med. 1996;24(12):1953-1961.
Ahlers SJGM, van Gulik L, van der Veen AM, et al. Comparison of different pain scoring systems in critically ill patients in a general ICU. Crit Care. 2008;12(1):1-8.
Zhu Y, Wang Y, Du B, Xi X. Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients? A systematic review and meta-analysis. Crit Care. 2017;21(1).
Copp MAB. Drug addiction. RN. 2009;72(4):40-44.
Chiu AW, Contreras S, Mehta S, et al. Iatrogenic Opioid Withdrawal in Critically Ill Patients: A Review of Assessment Tools and Management. Ann Pharmacother. 2017;51(12):1099-1111.
Azzam AAH, McDonald J, Lambert DG. Hot topics in opioid pharmacology: mixed and biased opioids. Br J Anaesth. 2019;122(6):e136-e145.
Chou R, Gordon DB, De Leon-Casasola OA, et al. Management of postoperative pain: A clinical practice guideline from the American pain society, the American society of regional anesthesia and pain medicine, and the American society of anesthesiologists’ committee on regional anesthesia, executive commi. J Pain. 2016;17(2):131-157.
Ehieli E, Yalamuri S, Brudney CS, Pyati S. Analgesia in the surgical intensive care unit. Postgrad Med J. 2017;93(1095):38-45.
Schell-Chaple HM, Liu KD, Matthay MA, Sessler DI, Puntillo KA. Effects of IV Acetaminophen on Core Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults: A Randomized Controlled Trial. Crit Care Med. 2017;45(7):1199-1207.
Longnecker, David E., Mackey Sean C., Newman, Mark F., Sandberg, Warren S., Zapol WM. Anesthesiology. 3rd ed. McGraw Hill Education; 2018.
Mateos Gaitan R, Vicent L, Rodriguez-Queralto O, et al. Dexmedetomidine in medical cardiac intensive care units. Data from a multicenter prospective registry. Int J Cardiol. 2020;310:162-166.
Olsen HT, Nedergaard HK, Strøm T, et al. Nonsedation or light sedation in critically ill, mechanically ventilated patients. N Engl J Med. 2020;382(12):1103-1111.
Shehabi Y, Bellomo R, Reade MC, et al. Early intensive care sedation predicts long-term mortality in ventilated critically ill patients. Am J Respir Crit Care Med. 2012;186(8):724-731.
Demertzi A, Laureys S. Annual Update in Intensive Care and Emergency Medicine 2019. Vol 1.; 2019.
Girard TD, Kress JP, Fuchs BD, Thomason JW, Schweickert WD, Pun BT, Taichman DB et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371:126-134.
Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: Validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338-1344.
Kress JP, Pohlman AS, O’Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342(20):1471-1477.
Lm A, Bucknall T, Kent B, Mitchell M, Burmeister E, Sj K. Protocol-directed sedation versus non-protocol-directed sedation in mechanically ventilated intensive care adults and children ( Review ) SUMMARY OF FINDINGS FOR THE MAIN COMPARISON. Cochrane Database Syst Rev. 2018;(11).
de Wit M, Gennings C, Jenvey WI, Epstein SK. Randomized trial comparing daily interruption of sedation and nursing-implemented sedation algorithm in medical intensive care unit patients. Crit Care. 2008;12(3):1-9.
Mehta S, Burry L, Cook D, et al. Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: A randomized controlled trial. JAMA - J Am Med Assoc. 2012;308(19):1985-1992.
Strøm T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet. 2010;375(9713):475-480.
Moraes F da S, Marengo LL, Silva MT, et al. ABCDE and ABCDEF care bundles: A systematic review protocol of the implementation process in intensive care units. Medicine (Baltimore). 2019;98(11):e14792.
Morandi A, Brummel NE, Ely EW. Sedation , delirium and mechanical ventilation : the ‘ ABCDE ’ approach. 2011.
Tool CPO, Bardwell J. Implementing the ABCDE Bundle , and Richmond Agitation-Sedation. 2020;31(1):16-21.
Kotfis K, Williams Roberson S, Wilson JE, Dabrowski W, Pun BT, Ely EW. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit Care. 2020;24(1):1-9.
van den Boogaard M, Wassenaar A, van Haren FMP, et al. Influence of sedation on delirium recognition in critically ill patients: A multinational cohort study. Aust Crit Care. 2020;(xxxx).
Zaal IJ, Devlin JW, Peelen LM, Slooter AJC. A systematic review of risk factors for delirium in the ICU. Crit Care Med. 2015;43(1):40-47.
Chen P, Jiang J, Zhang Y, et al. Effect of Dexmedetomidine on duration of mechanical ventilation in septic patients: A systematic review and meta-analysis. BMC Pulm Med. 2020;20(1):1-10.
Fraser GL, Devlin JW, Worby CP, et al. Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: A systematic review and meta-analysis of randomized trials. Crit Care Med. 2013;41(9 SUPPL.1):30-39.
Garratt C, Bratty JR. Dexmedetomidine vs Midazolam or Propofol for. Jama. 2012;307(11):1151-1160.
Winings NA, Daley BJ, Bollig RW, et al. Dexmedetomidine versus propofol for prolonged sedation in critically ill trauma and surgical patients. Surgeon. 2020;(xxxx).
Shehabi Y, Howe BD, Bellomo R, et al. Early sedation with dexmedetomidine in critically ill patients. N Engl J Med. 2019;380(26):2506-2517.
Ronald D. Miller, MD M. Miller’s Anesthesia. Vol 1.; 2015.
Glaess SS, Attridge RL, Christina Gutierrez G. Clonidine as a strategy for discontinuing dexmedetomidine sedation in critically ill patients: A narrative review. Am J Health Syst Pharm. 2020;77(7):515-522.
Ely EW, Margolin R, Francis J, et al. Evaluation of delirium in critically ill patients: Validation of the Confusion Assessment Method for the intensive care unit (CAM-ICU). Crit Care Med. 2001;29(7):1370-1379.
Bielka K, Kuchyn I, Glumcher F. Addition of dexmedetomidine to benzodiazepines for patients with alcohol withdrawal syndrome in the intensive care unit: a randomized controlled study. Ann Intensive Care. 2015;5(1).
Pizon AF, Lynch MJ, Benedict NJ, et al. Adjunct Ketamine Use in the Management of Severe Ethanol Withdrawal. Crit Care Med. 2018;46(8):e768-e771.
Greene RA, Zullo AR, Mailloux CM, Berard-Collins C, Levy MM, Amass T. Effect of best practice advisories on sedation protocol compliance and drug-related hazardous condition mitigation among critical care patients. Crit Care Med. 2020;5:185-191.
Laferriere-Langlois P, D’aragon F, Manzanares W. Halogenated volatile anesthetics in the intensive care unit: Current knowledge on an upcoming practice. Minerva Anestesiol. 2017;83(7):737-748.
Jerath A, Panckhurst J, Parotto M, et al. Safety and efficacy of volatile anesthetic agents compared with standard intravenous midazolam/propofol sedation in ventilated critical care patients: A meta-analysis and systematic review of prospective trials. Anesth Analg. 2017;124(4):1190-1199.
Heider J, Bansbach J, Kaufmann K, Heinrich S, Loop T, Kalbhenn J. Does volatile sedation with sevoflurane allow spontaneous breathing during prolonged prone positioning in intubated ARDS patients? A retrospective observational feasibility trial. Ann Intensive Care. 2019;9(1).
Jerath A, Ferguson ND, Cuthbertson B. Inhalational volatile ‑ based sedation for COVID ‑ 19 pneumonia and ARDS. Intensive Care Med. 2020.
Perbet S, Bourdeaux D, Sautou V, et al. A pharmacokinetic study of 48-hour sevoflurane inhalation using a disposable delivery system (AnaConDa®) in ICU patients. Minerva Anestesiol. 2014;80(6):655-665.
Jerath A, Ferguson ND, Steel A, Wijeysundera D, Macdonald J, Wasowicz M. The use of volatile anesthetic agents for long-term critical care sedation (VALTS): Study protocol for a pilot randomized controlled trial. Trials. 2015;16(1):2-7.
Kaplan, Joel A. M. Essentials of Cardiac Anesthesia for Cardiac Surgery. Vol 53. 2nd ed. (Elsevier, ed.).; 2018. file:///C:/Users/User/Downloads/fvm939e.pdf.
Hobl EL, Stimpfl T, Ebner J, et al. Morphine decreases clopidogrel concentrations and effects: A randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol. 2014;63(7):630-635.
Kubica J, Adamski P, Ostrowska M, et al. Morphine delays and attenuates ticagrelor exposure and actioninpatients with myocardial infarction: The randomized, double-blind, placebo-controlled IMPRESSION trial. Eur Heart J. 2016;37(3):245-252.
Lee SH, Choi YS, Hong GR, Oh YJ. Echocardiographic evaluation of the effects of dexmedetomidine on cardiac function during total intravenous anaesthesia. Anaesthesia. 2015;70(9):1052-1059.
Khalil M, Al-Agaty A, Asaad O, et al. A comparative study between propofol and dexmedetomidine as sedative agents during performing transcatheter aortic valve implantation. J Clin Anesth. 2016;32:242-247.
Morelli A, Sanfilippo F, Arnemann P, et al. The effect of propofol and dexmedetomidine sedation on norepinephrine requirements in septic shock patients: A crossover trial. Crit Care Med. 2019;47(2):E89-E95.
Marler J, Mohrien K, Kimmons LA, et al. Effects of propofol on vasopressor use in patients with sepsis and severe sepsis: A pilot study. J Crit Care. 2016;35:155-160.
Reese JM, Sullivan VF, Boyer NL, Mount CA. A Non-Comparative Prospective Pilot Study of Ketamine for Sedation in Adult Septic Shock. Mil Med. 2018;183(11-12):E409-E413.
The National Heart, Lung and BIPCTN. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. N Engl J Med. 2019.
Papazian L, Forel JM, Gacouin A, Ragon-Penot C et al. Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome. N Engl J Med. 2010;363(12).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Maria Ana Máximo, Andreia Puga
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Articles are freely available to be read, downloaded and shared from the time of publication.
The RSPA reserves the right to commercialize the article as an integral part of the journal (in the preparation of reprints, for example). The author should accompany the submission letter with a declaration of copyright transfer for commercial purposes.
Articles are published under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC).
After publication in RSPA, authors are allowed to make their articles available in repositories of their home institutions, as long as they always mention where they were published.
